Data sourcesSEC Form 423m ago
House PTR22m ago
SEC 13F22m ago
Robinhood Chain22m ago
Public companyDBV Technologies S.A.
DBVTCIK 0001613780
Price$10.45
1 year-25.9%
Disclosed transactions8
Buys / sells0 / 2
Max Insider Score31
Connections with evidence5
DBVT · disclosed activity on price
| Score | Actor | Security | Side | Value | Executed | Disclosed | Lag | Source | Evidence |
|---|
| 5 | MPMohideen PharisChief Medical Officer | DBVTDBV Technologies S.A. Grant or award | A | — 253.0K sh | Nov 21, 2025 | Nov 25, 2025 |
| 17 | MPMohideen PharisChief Medical Officer | DBVTDBV Technologies S.A. Open-market sale | SELL | $4,498 1,624 sh | Nov 21, 2025 | Nov 25, 2025 traded Nov 21, 2025 | +4d | SEC Form 4 | |
| 31 | MPMohideen PharisChief Medical Officer | DBVTDBV Technologies S.A. Open-market sale | SELL | $19K 6,496 sh | Nov 20, 2025 | Nov 25, 2025 traded Nov 20, 2025 | +5d | SEC Form 4 | |
| 13 | MPMohideen PharisChief Medical Officer | DBVTDBV Technologies S.A. Grant or award | A | — 44.0K sh | Nov 21, 2025 | Nov 25, 2025 traded Nov 21, 2025 | +4d | SEC Form 4 | |
| 9 | BVBoucinha VirginieChief Financial Officer | DBVTDBV Technologies S.A. Grant or award | A | — 192.0K sh | Nov 21, 2025 | Nov 24, 2025 traded Nov 21, 2025 | +3d | SEC Form 4 | |
| 9 | TMTrapp Kevin MichaelChief Commercial Officer | DBVTDBV Technologies S.A. Grant or award | A | — 316.3K sh | Nov 21, 2025 | Nov 24, 2025 traded Nov 21, 2025 | +3d | SEC Form 4 | |
| 21 | BVBoucinha VirginieChief Financial Officer | DBVTDBV Technologies S.A. Grant or award | A | — 32.0K sh | Nov 21, 2025 | Nov 24, 2025 traded Nov 21, 2025 | +3d | SEC Form 4 | |
| 9 | TMTrapp Kevin MichaelChief Commercial Officer | DBVTDBV Technologies S.A. Grant or award | A | — 55.0K sh | Nov 21, 2025 | Nov 24, 2025 traded Nov 21, 2025 | +3d | SEC Form 4 | |
Chief Financial Officer · Nov 24, 2025